Abstract

Bovine African Trypanosomosis is an infectious parasitic disease affecting livestock productivity and thereby impairing the economic development of Sub-Saharan Africa. The most important trypanosome species implicated is T. congolense, causing anemia as most important pathological feature. Using murine models, it was shown that due to the parasite's efficient immune evasion mechanisms, including (i) antigenic variation of the variable surface glycoprotein (VSG) coat, (ii) induction of polyclonal B cell activation, (iii) loss of B cell memory and (iv) T cell mediated immunosuppression, disease prevention through vaccination has so far been impossible. In trypanotolerant models a strong, early pro-inflammatory immune response involving IFN-γ, TNF and NO, combined with a strong humoral anti-VSG response, ensures early parasitemia control. This potent protective inflammatory response is counterbalanced by the production of the anti-inflammatory cytokine IL-10, which in turn prevents early death of the host from uncontrolled hyper-inflammation-mediated immunopathologies. Though at this stage different hematopoietic cells, such as NK cells, T cells and B cells as well as myeloid cells (i.e. alternatively activated myeloid cells (M2) or Ly6c- monocytes), were found to produce IL-10, the contribution of non-hematopoietic cells as potential IL-10 source during experimental T. congolense infection has not been addressed. Here, we report for the first time that during the chronic stage of T. congolense infection non-hematopoietic cells constitute an important source of IL-10. Our data shows that hepatocyte-derived IL-10 is mandatory for host survival and is crucial for the control of trypanosomosis-induced inflammation and associated immunopathologies such as anemia, hepatosplenomegaly and excessive tissue injury.

Highlights

  • African trypanosomes are extracellular protozoan parasites transmitted by the bite of infected tsetse flies, causing sleeping sickness in humans and Nagana disease in cattle in sub-Saharan Africa

  • It was shown that the disease is characterized by a well-timed and balanced production of proinflammatory cytokine promoting factors followed by an anti-inflammatory response, involving IL-10

  • The cellular source of IL-10 in vivo and the window within which these cells exert their function during the course of African trypanosomiasis remain poorly understood, which hampers the design of effective therapeutic strategies

Read more

Summary

Introduction

African trypanosomes are extracellular protozoan parasites transmitted by the bite of infected tsetse flies (genus Glossina), causing sleeping sickness in humans and Nagana disease in cattle in sub-Saharan Africa. The infection is characterized by two stages; during the early stage there is a strong inflammatory immune response mediated by T cells and involving classically IFN-γ-activated myeloid cells (so-called M1) required for the efficient control of the first most prominent parasitemia peak through their production of trypanotoxic molecules, such as Hepatocyte-IL-10 attenuates African trypanosomiasis-associated pathogenicity nitric oxide (NO) and Tumor Necrosis Factor (TNF), and the phagocytosis of antibody-opsonized parasites that occurs mainly in the liver [8,9,10,11,12] This is followed by the production of the anti-inflammatory cytokine IL-10, which is essential to dampen the inflammatory immune response after parasitemia has been cleared and to prevent tissue damage as well as death of the host due to a hyper-inflammation syndrome [13,14,15,16]. Knowledge about the inflammation resolution process is necessary to understand the host-parasite interplay and might pave the way to improve or develop more efficient therapies that reduce the devastating effect of chronic protozoan infections [21]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call